引 致 更 改 給 病 人 的 產 品 資 訊 的 藥 物 不 良 反 應 警 示
|
| |
| Updated Labelling for piroxicam in Canada which the drug should no longer to be used for acute pain or inflammation (English only) |
| |
Health Canada has conducted a safety review and concluded that piroxicam should no longer be used to treat short-term pain and inflammation due to an increased risk of serious skin reactions and gastrointestinal problems relative to other similar drugs. Piroxicam can still be prescribed for the symptomatic relief of chronic pain and inflammation in patients suffering from certain types of chronic arthritis (osteoarthritis, rheumatoid arthritis and ankylosing spondylitis). The relevant link for the news is:
http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2009/2009_102-eng.php
Situation in Hong Kong: Since July 2007, following the recommendation of the EU agency, the use of piroxicam-containing products has been limited only to the symptomatic relief of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. The acute pain and inflammatory conditions were abandoned.
Ends/Monday, June 29, 2009
Issued at HKT 12:30
|
| |
